Literature DB >> 12163598

Direct and quantitative single-cell analysis of human immunodeficiency virus type 1 reactivation from latency.

Olaf Kutsch1, Etty N Benveniste, George M Shaw, David N Levy.   

Abstract

The ability of human immunodeficiency virus type 1 (HIV-1) to establish latent infections in cells has received renewed attention owing to the failure of highly active antiretroviral therapy to eradicate HIV-1 in vivo. Despite much study, the molecular bases of HIV-1 latency and reactivation are incompletely understood. Research on HIV-1 latency would benefit from a model system that is amenable to rapid and efficient analysis and through which compounds capable of regulating HIV-1 reactivation may be conveniently screened. We describe a novel reporter system that has several advantages over existing in vitro systems, which require elaborate, expensive, and time-consuming techniques to measure virus production. Two HIV-1 molecular clones (NL4-3 and 89.6) were engineered to express enhanced green fluorescent protein (EGFP) under the control of the viral long terminal repeat without removing any viral sequences. By using these replication-competent viruses, latently infected T-cell (Jurkat) and monocyte/macrophage (THP-1) lines in which EGFP fluorescence and virus expression are tightly coupled were generated. Following reactivation with agents such as tumor necrosis factor alpha, virus expression and EGFP fluorescence peaked after 4 days and over the next 3 weeks each declined in a synchronized manner, recapitulating the establishment of latency. Using fluorescence microscopy, flow cytometry, or plate-based fluorometry, this system allows immediate, direct, and quantitative real-time analysis of these processes within single cells or in bulk populations of cells. Exploiting the single-cell analysis abilities of this system, we demonstrate that cellular activation and virus reactivation following stimulation with proinflammatory cytokines can be uncoupled.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12163598      PMCID: PMC136999          DOI: 10.1128/jvi.76.17.8776-8786.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

1.  Transcription of HIV1 is inhibited by DNA methylation.

Authors:  K Schulze-Forster; F Götz; H Wagner; H Kröger; D Simon
Journal:  Biochem Biophys Res Commun       Date:  1990-04-16       Impact factor: 3.575

2.  Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency.

Authors:  R J Pomerantz; D Trono; M B Feinberg; D Baltimore
Journal:  Cell       Date:  1990-06-29       Impact factor: 41.582

3.  Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line.

Authors:  T M Folks; J Justement; A Kinter; C A Dinarello; A S Fauci
Journal:  Science       Date:  1987-11-06       Impact factor: 47.728

4.  Repression of HIV-1 transcription by a cellular protein.

Authors:  H Kato; M Horikoshi; R G Roeder
Journal:  Science       Date:  1991-03-22       Impact factor: 47.728

5.  Oscillation of the human immunodeficiency virus surface receptor is regulated by the state of viral activation in a CD4+ cell model of chronic infection.

Authors:  S T Butera; V L Perez; B Y Wu; G J Nabel; T M Folks
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

6.  Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat.

Authors:  E J Duh; W J Maury; T M Folks; A S Fauci; A B Rabson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

7.  The cAMP-dependent protein kinase A and protein kinase C-beta pathways synergistically interact to activate HIV-1 transcription in latently infected cells of monocyte/macrophage lineage.

Authors:  M F Rabbi; L al-Harthi; M Saifuddin; K A Roebuck
Journal:  Virology       Date:  1998-06-05       Impact factor: 3.616

8.  Activation of HIV gene expression during monocyte differentiation by induction of NF-kappa B.

Authors:  G E Griffin; K Leung; T M Folks; S Kunkel; G J Nabel
Journal:  Nature       Date:  1989-05-04       Impact factor: 49.962

9.  An HIV-1-infected T cell clone defective in IL-2 production and Ca2+ mobilization after CD3 stimulation.

Authors:  V L Perez; T Rowe; J S Justement; S T Butera; C H June; T M Folks
Journal:  J Immunol       Date:  1991-11-01       Impact factor: 5.422

10.  Inactivation of the HIV LTR by DNA CpG methylation: evidence for a role in latency.

Authors:  D P Bednarik; J A Cook; P M Pitha
Journal:  EMBO J       Date:  1990-04       Impact factor: 11.598

View more
  106 in total

1.  Hit-and-run stimulation: a novel concept to reactivate latent HIV-1 infection without cytokine gene induction.

Authors:  Frank Wolschendorf; Alexandra Duverger; Jennifer Jones; Frederic H Wagner; Jason Huff; William H Benjamin; Michael S Saag; Michael Niederweis; Olaf Kutsch
Journal:  J Virol       Date:  2010-06-10       Impact factor: 5.103

2.  Dynamics of HIV-1 recombination in its natural target cells.

Authors:  David N Levy; Grace M Aldrovandi; Olaf Kutsch; George M Shaw
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-09       Impact factor: 11.205

3.  Kinase control prevents HIV-1 reactivation in spite of high levels of induced NF-κB activity.

Authors:  Frank Wolschendorf; Alberto Bosque; Takao Shishido; Alexandra Duverger; Jennifer Jones; Vicente Planelles; Olaf Kutsch
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

4.  Polybacterial challenge enhances HIV reactivation in latently infected macrophages and dendritic cells.

Authors:  Chifu B Huang; Yelena V Alimova; Samantha Strange; Jeffrey L Ebersole
Journal:  Immunology       Date:  2010-11-12       Impact factor: 7.397

5.  Histonedeacetylase inhibitor Oxamflatin increase HIV-1 transcription by inducing histone modification in latently infected cells.

Authors:  Hao Yin; Yuhao Zhang; Xin Zhou; Huanzhang Zhu
Journal:  Mol Biol Rep       Date:  2010-12-23       Impact factor: 2.316

6.  Replication competent molecular clones of HIV-1 expressing Renilla luciferase facilitate the analysis of antibody inhibition in PBMC.

Authors:  Tara G Edmonds; Haitao Ding; Xing Yuan; Qing Wei; Kendra S Smith; Joan A Conway; Lindsay Wieczorek; Bruce Brown; Victoria Polonis; John T West; David C Montefiori; John C Kappes; Christina Ochsenbauer
Journal:  Virology       Date:  2010-09-21       Impact factor: 3.616

7.  Stable Phenotypic Changes of the Host T Cells Are Essential to the Long-Term Stability of Latent HIV-1 Infection.

Authors:  Lillian Seu; Steffanie Sabbaj; Alexandra Duverger; Frederic Wagner; Joshua C Anderson; Elizabeth Davies; Frank Wolschendorf; Christopher D Willey; Michael S Saag; Paul Goepfert; Olaf Kutsch
Journal:  J Virol       Date:  2015-04-15       Impact factor: 5.103

8.  Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid.

Authors:  Nancie M Archin; Amy Espeseth; Daniel Parker; Manzoor Cheema; Daria Hazuda; David M Margolis
Journal:  AIDS Res Hum Retroviruses       Date:  2009-02       Impact factor: 2.205

9.  BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism.

Authors:  Daniela Boehm; Vincenzo Calvanese; Roy D Dar; Sifei Xing; Sebastian Schroeder; Laura Martins; Katherine Aull; Pao-Chen Li; Vicente Planelles; James E Bradner; Ming-Ming Zhou; Robert F Siliciano; Leor Weinberger; Eric Verdin; Melanie Ott
Journal:  Cell Cycle       Date:  2012-02-01       Impact factor: 4.534

10.  Determinants of the establishment of human immunodeficiency virus type 1 latency.

Authors:  Alexandra Duverger; Jennifer Jones; Jori May; Frederic Bibollet-Ruche; Frederic A Wagner; Randall Q Cron; Olaf Kutsch
Journal:  J Virol       Date:  2009-01-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.